First in Man Study of Safety, Tolerability and PK Profile of RBP-7000
NCT02765555
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
RBP-7000
Sponsor
Indivior Inc.